Changing the paradigm of active ingredient encapsulation
Matralix aims to revolutionize the encapsulation industry by developing precision encapsulation systems that significantly enhance the productivity of formulations scientists and the quality of the final product over conventional batch methods.
Moving from batch to continuous production
When it comes to early stage exploration and discovery of lipid –based formulations, there is a need to look beyond the traditional methods such as melt spray congeal (MSC). Although MSC is an industry standard, it poses several challenges for a formulations scientist in terms of the minimal volumes that can be handled, the tunability of the process itself and the quality of the products obtained.
To address these challenges, Matralix has developed a continuous flow-based, low footprint microencapsulation system that requires minimal sample volumes and is highly tunable – allowing a scientist to produce a series of products during a single production run.
Decreased development risk, costs and time to market
Matralix Technology offers unprecedented particle size control compared to traditional methods. This eliminates the need for downstream processing such as sieving. With the ability to change process parameters during a run, a range of products of different sizes can also be achieved.
Microparticles to Microcapsules
Matralix Technology can handle a range of active ingredients (micronised solids, lipophilic and aqueous actives) and particle architectures
PARTNERING WITH MATRALIX
We work with our customers in developing and prototyping new products and also delivering scalable technology solutions from the lab bench to manufacturing